Immediate Impact
61 standout
Citing Papers
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19
2024 Standout
Works of Annie Gardner being referenced
1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo
2022
Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Annie Gardner | 21 | 112 | 71 | 90 | 85 | 9 | 303 | |
| David Gozzard | 24 | 45 | 40 | 10 | 24 | 15 | 288 | |
| Jorge Castagnino | 151 | 145 | 134 | 20 | 36 | 18 | 351 | |
| Paola Bresciani | 10 | 23 | 21 | 27 | 9 | 10 | 268 | |
| Anne Gedebjerg | 11 | 85 | 57 | 10 | 7 | 10 | 300 | |
| Stéphane Gayet | 9 | 45 | 15 | 180 | 24 | 14 | 335 | |
| A. M. Worsley | 27 | 19 | 56 | 21 | 35 | 11 | 354 | |
| Grace K. Kim | 23 | 100 | 80 | 45 | 53 | 13 | 367 | |
| Pablo González Montaner | 174 | 56 | 128 | 19 | 33 | 11 | 263 | |
| Inbal Shafran | 74 | 82 | 63 | 19 | 5 | 16 | 319 | |
| Juliet Hockenhull | 5 | 16 | 14 | 18 | 41 | 9 | 361 |
All Works
Loading papers...